New SCCS Mandate for Butylparaben on Children’s Exposure

New SCCS Mandate for Prostaglandin Analogues

On 27 March 2024, the Scientific Committee on Consumer Safety (SCCS) adopted a new mandate to review the safety of prostaglandin analogues (ethyl tafluprostamide – DDDE, methylamido-dihydro-noralfaprostal – MDN, and isopropyl cloprostenate – IPCP) in...
New SCCS Mandate for Butylparaben on Children’s Exposure

Draft SCCS Opinion on Citral

On 4 April 2024, the Scientific Committee on Consumer Safety (SCCS) issued its draft opinion on the safety of citral in cosmetic products. It can be accessed here. The SCCS concluded that the assessment based on QRA2 methodology has indicated that citral can be...
New SCCS Mandate for Butylparaben on Children’s Exposure

Draft SCCS Opinion on Triphenyl Phosphate

On 4 April 2024, the Scientific Committee on Consumer Safety (SCCS) issued its draft opinion on the safety of triphenyl phosphate when used as a plasticiser in nail products at 5%.  It can be accessed here. The SCCS concluded that it is not possible to conclude...